Kushagra Maini, MD
Neurology · Little River, SCNPI 1932620259
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (49.6%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Medtronic accounts for 69.0% of it on its own, with 33 other manufacturers making up the rest. Reporting peaked in 2021 at $7,510 and has fallen 98.4% since, to $122 in 2025.
Across 163 payments — averaging $91.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$10K
- Abbott$3K
- Nevro Corp.$253
- Inari Medical, Inc.$196
- Teva Pharmaceuticals USA, Inc.$189
- Avanos Medical$133
- plus $1K from 28 others
What the payments were for
- Grants$7,41850%
- Travel & lodging$2,76418%
- Food & beverage$4,76332%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 71 | $10,307 |
| Abbott | 22 | $2,849 |
| Nevro Corp. | 6 | $253 |
| Inari Medical, Inc. | 1 | $196 |
| Teva Pharmaceuticals USA, Inc. | 10 | $189 |
| Avanos Medical | 3 | $133 |
| Greenwich Biosciences, Inc. | 7 | $119 |
| Boston Scientific | 3 | $100 |
| AstraZeneca | 5 | $98 |
| AbbVie | 5 | $93 |
| Novartis | 3 | $62 |
| Pfizer | 3 | $51 |
| Heraeus Medical, LLC. | 1 | $39 |
| Vertos Medical, Inc. | 2 | $39 |
| Si-bone, Inc. | 2 | $34 |
| Forte Bio-pharma LLC | 1 | $32 |
| Sanofi-aventis U.S. LLC | 1 | $24 |
| SPR Therapeutics, Inc | 1 | $24 |
| Averitas Pharma Inc. | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Acadia Pharmaceuticals Inc | 1 | $23 |
| Painteq LLC | 1 | $22 |
| Vertex | 1 | $21 |
| Argenx US, Inc. | 1 | $20 |
| Akcea Therapeutics, Inc. | 1 | $20 |
| Neurelis, Inc. | 1 | $20 |
| Alnylam Pharmaceuticals Inc. | 1 | $19 |
| Acacia Pharma Inc | 1 | $18 |
| UCB, Inc. | 1 | $18 |
| Livanova USA, Inc. | 1 | $17 |
| Saluda Medical Americas, Inc. | 1 | $17 |
| Nalu Medical, Inc. | 1 | $15 |
| Cala Health, Inc. | 1 | $15 |
| Relievant Medsystems, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNCHROMED$7,267
- PROCLAIM$2,437
- OSTEOCOOL RF ABLATION SYSTEM$824
- INTELLIS ADAPTIVESTIM$639
- FLOWTRIEVER CATHETER, S$196
- CT THROMBECTOMY SYSTEM KIT$196
- SYNCHROMEDII$151
- Omnia$121
- INJEX$118
How this compares
$14,945 in reported general payments places this provider in the 80th percentile of 270 neurology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GlatopaGlatiramer Acetate | 11 | $27,100 |
| Nurtec OdtRimegepant Sulfate | 19 | $26,625 |
| Lidocaine | 80 | $11,331 |
| Pregabalin | 275 | $4,906 |
| Gabapentin | 383 | $4,331 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 378 | $4,034 |
| Duloxetine Hcl | 215 | $3,973 |
| Diclofenac Sodium | 250 | $3,135 |
| Tizanidine Hcl | 466 | $2,831 |
| Celecoxib | 128 | $2,619 |
| Dimethyl Fumarate | 12 | $1,213 |
| Memantine Hcl | 44 | $1,203 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 60 | $993 |
| Oxycodone Hcl | 61 | $945 |
| Desonide | 13 | $893 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerNurtec Odt | $51 | $26,62519 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 270 neurology providers in South Carolina.
Other neurology in Little River
- Olinda SpencerLittle River$44K
- John BakerSumter$779K
- Robert CarlileSummerville$428K
- Mary HughesGreenville$404K
- Jose CardenasAiken$216K
- Fredy RevillaGreenville$208K
- Robert AdamsCharleston$204K
- Thomas HughesMt. Pleasant$102K
- Kathleen WoschkolupGreenville$97K
- Sarah BreevoortCharleston$90K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.